World first Australian and New Zealand trial of cannabidiol transdermal gel for the most common hard-to-treat epilepsy type in adults - Monash University

11 July 2022 Professor Terry O'Brien has led a trial using transdermal CBD gel in adults with focal epilepsy. After 6 months of treatment, over half the patients experienced a 50%+ reduction in seiz… [+3302 chars]

full article...